Cargando…
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer()
The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 act...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757665/ https://www.ncbi.nlm.nih.gov/pubmed/24024136 http://dx.doi.org/10.1016/j.redox.2012.10.001 |
_version_ | 1782282242375024640 |
---|---|
author | Kansanen, Emilia Kuosmanen, Suvi M. Leinonen, Hanna Levonen, Anna-Liisa |
author_facet | Kansanen, Emilia Kuosmanen, Suvi M. Leinonen, Hanna Levonen, Anna-Liisa |
author_sort | Kansanen, Emilia |
collection | PubMed |
description | The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth. In this graphical review, we provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells. We also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy. |
format | Online Article Text |
id | pubmed-3757665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-37576652013-09-10 The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() Kansanen, Emilia Kuosmanen, Suvi M. Leinonen, Hanna Levonen, Anna-Liisa Redox Biol Review Article The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth. In this graphical review, we provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells. We also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy. Elsevier 2013-01-18 /pmc/articles/PMC3757665/ /pubmed/24024136 http://dx.doi.org/10.1016/j.redox.2012.10.001 Text en © 2013 The Authors http://creativecommons.org/licenses/BY-license/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Article Kansanen, Emilia Kuosmanen, Suvi M. Leinonen, Hanna Levonen, Anna-Liisa The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() |
title | The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() |
title_full | The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() |
title_fullStr | The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() |
title_full_unstemmed | The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() |
title_short | The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer() |
title_sort | keap1-nrf2 pathway: mechanisms of activation and dysregulation in cancer() |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757665/ https://www.ncbi.nlm.nih.gov/pubmed/24024136 http://dx.doi.org/10.1016/j.redox.2012.10.001 |
work_keys_str_mv | AT kansanenemilia thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer AT kuosmanensuvim thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer AT leinonenhanna thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer AT levonenannaliisa thekeap1nrf2pathwaymechanismsofactivationanddysregulationincancer AT kansanenemilia keap1nrf2pathwaymechanismsofactivationanddysregulationincancer AT kuosmanensuvim keap1nrf2pathwaymechanismsofactivationanddysregulationincancer AT leinonenhanna keap1nrf2pathwaymechanismsofactivationanddysregulationincancer AT levonenannaliisa keap1nrf2pathwaymechanismsofactivationanddysregulationincancer |